Effects of a 12-month treatment with glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on oxidant and antioxidant biomarkers in patients with type 2 diabetes
Scirica, director of quality initiatives at Brigham and Womens Hospitals Cardiovascular Division and lead author of the study
10.1038/nrm2934 49 SieberJ.WeinsA.KampeK.GruberS.LindenmeyerM
Most people regain significant weight within 12 months of discontinuation, not because the drug wore off, but because the biological suppression it provided disappears
Beyond the numbers, they reported feeling healthier and more energized, with greater ability to do the things they love
These results were verified in the pSS and control groups